Novo Nordisk’s bid for Metsera raises potential concerns, US FTC's Guarnera says
The Federal Trade Commission has warned Novo Nordisk and Metsera that Novo’s restructured plan to buy Metsera, including a considerable upfront payment, may violate US premerger notification laws. FTC Bureau of...To view the full article, register now.
Already a subscriber? Click here to view full article